Please assess the completion status of the following clinical trial:

Trial Title: Neurologic Injuries in Adults With Urea Cycle Disorders

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria for Participants with OTCD:~* Diagnosis of OTCD or heterozygote state of OTCD by metabolic or molecular means. Female participants must be clinically stable and heterozygous for OTCD. Male participants must be hemizygous for late onset OTCD.~Inclusion Criteria for Healthy Controls:~* No known medical or metabolic disorder~Inclusion Criteria for All Participants:~* IQ of at least 80~* Willing to travel to study site~* English-speaking~* Age between 18 and 60 years~Exclusion Criteria for All Participants:~* Currently being treated for an acute illness~* History of neuropsychiatric drug use~* Unable to undergo MRI scanning without being sedated~* Unable to participate in neurocognitive and/or motor testing~* Metal device in body that might interfere with MRI scanning~* Pregnancy or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: None): Female carriers of ornithine transcarbamylase deficiency (OTCD) or males with late onset presentation of OTCD
- 2 (Type: None): Healthy males or females without known medical or metabolic disorder (control group)

Based on this trial design, predict the completion outcome and termination type (if applicable).